Cargando…
Dapagliflozin reverses the imbalance of T helper 17 and T regulatory cells by inhibiting SGK1 in a mouse model of diabetic kidney disease
An imbalance between T helper 17 (Th17) and T regulatory (Treg) cell subsets contributes to the pathogenesis of diabetic kidney disease (DKD). However, the underlying regulatory mechanisms that cause this imbalance are unknown. Serum/glucocorticoid‐regulated kinase 1 (SGK1) has been suggested to aff...
Autores principales: | Wang, Dan, Zhang, Zikun, Si, Zekun, Yang, Yanlin, Li, Shuangshuang, Xue, Yaoming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8091586/ https://www.ncbi.nlm.nih.gov/pubmed/33728820 http://dx.doi.org/10.1002/2211-5463.13147 |
Ejemplares similares
-
T-Helper 17 Cell/Regulatory T-Cell Imbalance in COPD Combined with T2DM Patients
por: Wang, Cheng, et al.
Publicado: (2021) -
SGK1 Governs the Reciprocal Development of Th17 and Regulatory T Cells
por: Wu, Chuan, et al.
Publicado: (2018) -
Dapagliflozin attenuates diabetes-induced diastolic dysfunction and cardiac fibrosis by regulating SGK1 signaling
por: Lee, Seul-Gee, et al.
Publicado: (2022) -
T-regulatory cell/T helper 17 cell imbalance functions as prognostic biomarker of oral squamous cell carcinoma – CONSORT
por: Wang, Lin, et al.
Publicado: (2020) -
Th17/Regulatory T-Cell Imbalance and Acute Kidney Injury in Patients with Sepsis
por: Zhou, Xiao, et al.
Publicado: (2022)